Cargando…
Early diagnosis of infantile-onset lysosomal acid lipase deficiency in the advent of available enzyme replacement therapy
BACKGROUND: Lysosomal acid lipase deficiency (LAL-D) is an autosomal recessive disorder that can present as a severe, infantile form also known as Wolman disease. We sought to determine the outcomes and clinical needs of infants diagnosed with LAL-D, treated with enzyme replacement therapy (ERT). ME...
Autores principales: | Cohen, Jennifer L., Burfield, Jessica, Valdez-Gonzalez, Karen, Samuels, Angela, Stefanatos, Arianna K., Yudkoff, Marc, Pedro, Helio, Ficicioglu, Can |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692931/ https://www.ncbi.nlm.nih.gov/pubmed/31412917 http://dx.doi.org/10.1186/s13023-019-1129-y |
Ejemplares similares
-
Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency
por: Pritchard, Amanda Barone, et al.
Publicado: (2020) -
Lipases in lysosomes, what for?
por: Czaja, Mark J., et al.
Publicado: (2009) -
Enzyme replacement therapy in lysosomal acid lipase deficiency
(LAL-D): a systematic literature review
por: Bashir, Aamir, et al.
Publicado: (2021) -
S2.2 Enzyme replacement therapy
in the infantile-onset Pompe disease
por: Parenti, Giancarlo, et al.
Publicado: (2011) -
Lysosomal acid lipase in cancer
por: Yan, Cong, et al.
Publicado: (2015)